Hyperacute graft rejection is: (A) Type I hypersensitivity, (B) Type II hypersensitivity, (C) Type III hypersensitivity, (D) Type Iv hypersensitivity
Answer is B. In this case preformed circulating antibody binds to graft endothelial HLA and also activates complement system.
Hence, this is Type II HS.